Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects

被引:19
作者
De Bree, A
Verschuren, WMM
Kromhout, D
Mennen, LI
Blom, HJ
机构
[1] INRA, U1125, INSERM,U557, ISTNA, F-75003 Paris, France
[2] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[3] Univ Med Ctr St Radboud, Lab Pediat & Neurol, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1093/ije/31.6.1268
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:1268 / 1270
页数:3
相关论文
共 35 条
[1]  
A'Brook R., 1998, European Heart Journal, V19, P8
[2]   RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].
ALFTHAN, G ;
PEKKANEN, J ;
JAUHIAINEN, M ;
PITKANIEMI, J ;
KARVONEN, M ;
TUOMILEHTO, J ;
SALONEN, JT ;
EHNHOLM, C .
ATHEROSCLEROSIS, 1994, 106 (01) :9-19
[3]   SERUM TOTAL HOMOCYSTEINE AND CORONARY HEART-DISEASE [J].
ARNESEN, E ;
REFSUM, H ;
BONAA, KH ;
UELAND, PM ;
FORDE, OH ;
NORDREHAUG, JE .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (04) :704-709
[4]   Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients - A prospective study [J].
Bostom, AG ;
Shemin, D ;
Verhoef, P ;
Nadeau, MR ;
Jacques, PF ;
Selhub, J ;
Dworkin, L ;
Rosenberg, IH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2554-2558
[5]   Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women [J].
Bostom, AG ;
Silbershatz, H ;
Rosenberg, IH ;
Selhub, J ;
D'Agostino, RB ;
Wolf, PA ;
Jacques, PF ;
Wilson, PWF .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1077-1080
[6]   Homocysteine and short-term risk of myocardial infarction and stroke in the elderly -: The Rotterdam study [J].
Bots, ML ;
Launer, LJ ;
Lindemans, J ;
Hoes, AW ;
Hofman, A ;
Witteman, JCM ;
Koudstaal, PJ ;
Grobbee, DE .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (01) :38-44
[7]   Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease -: The result of a meta-analysis [J].
Brattström, L ;
Wilcken, DEL ;
Öhrvik, J ;
Brudin, L .
CIRCULATION, 1998, 98 (23) :2520-2526
[8]  
ChasanTaber L, 1996, J AM COLL NUTR, V15, P136
[9]   Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements [J].
Clarke, R ;
Armitage, J .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (03) :341-348
[10]  
DEBREE A, 2001, THESIS KATHOLIEKE U